• Sobr Safe faces potential Nasdaq delisting after its stock traded below the $1 bid-price minimum for 30 consecutive business days.
• Nasdaq denied a standard 180-day cure period due to cumulative reverse splits of 1-for-1,100 over the past two years.
• Nasdaq hearings panel granted a stay, allowing continued listing until Sept. 15, 2026.
• Continued listing hinges on completing a proposed business combination with Clean World Ventures by Sept. 15, 2026, then meeting initial listing rules.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sobr Safe Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-003444), on May 27, 2026, and is solely responsible for the information contained therein.